<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="utf-8">
  <meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
  <title>Distribution pattern and prevalence of West Nile virus infection in Nigeria from 1950 to 2020: a systematic review - VetSRev</title>
  <link rel="stylesheet" href="/vendor/bootstrap-4.3.1.min.css">
  <link rel="stylesheet" href="/vendor/fontawesome-5.8.1.min.css">

  <link rel="preconnect" href="https://fonts.googleapis.com">
  <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
  <link href="https://fonts.googleapis.com/css2?family=Roboto:ital,wght@0,100;0,300;0,400;0,700;1,400&display=swap" rel="stylesheet">

  <link rel="stylesheet" href="/assets/style.css" media="screen" type="text/css">

  <link rel="apple-touch-icon" sizes="180x180" href="/apple-touch-icon.png">
  <link rel="icon" type="image/png" sizes="32x32" href="/favicon-32x32.png">
  <link rel="icon" type="image/png" sizes="16x16" href="/favicon-16x16.png">
  <link rel="manifest" href="/site.webmanifest">
</head>

<body>
  <!-- HEADER -->
  <div class="header">
    <div class="container">
      <img src="/assets/CEVMLogo.png" alt="logo"/>
      <div class="title">
        <h1>VetSRev</h1>
        <p class="hidden-xs">Database of veterinary systematic reviews</p>
      </div>
    </div>
  </div>

  <!-- Navigation -->
  <div class="container">
    <nav class="navbar navbar-expand navbar-light bg-light">
      <button class="navbar-toggler" type="button" data-toggle="collapse" data-target="#navbarSupportedContent" aria-controls="navbarSupportedContent" aria-expanded="false" aria-label="Toggle navigation">
        <span class="navbar-toggler-icon"></span>
      </button>

      <div class="collapse navbar-collapse" id="navbarSupportedContent">
        <ul class="navbar-nav mr-auto">
          <li class="nav-item"><a class="nav-link" href="/">Home</a></li>
          <li class="nav-item"><a class="nav-link" href="/about.html">About VetSRev</a></li>
        </ul>
      </div>
    </nav>
  </div>

  <!-- CONTENT -->
  <div class="container">
  <div class="publication">
  <h1>Distribution pattern and prevalence of West Nile virus infection in Nigeria from 1950 to 2020: a systematic review</h1>
  <h2>Abdullahi, I. N. and Emeribe, A. U. and Ghamba, P. E. and Omosigho, P. O. and Bello, Z. M. and Oderinde, B. S. and Fasogbon, S. A. and Olayemi, L. and Daneji, I. M. and Musa, M. H. and Nwofe, J. O. and Onukegbe, N. B. and Okume, C. C. and Musa, S. and Gwarzo, A. M. and Ajagbe, O. O. R.</h2>

  
  <p>Epidemiol Health (2020) 42: e2020071</p>
  

  
  <p>DOI: <a href="https://doi.org/10.4178/epih.e2020071">10.4178/epih.e2020071</a></p>
  

  
  <h2>Abstract</h2>
  <p>OBJECTIVES: West Nile virus (WNV) is a re-emerging mosquito-borne viral infection. This study investigated the pooled prevalence pattern and risk factors of WNV infection among humans and animals in Nigeria. METHODS: A systematic review was conducted of eligible studies published in PubMed, Scopus, Google Scholar, and Web of Science from January 1, 1950 to August 30, 2020. Peer-reviewed cross-sectional studies describing WNV infections in humans and animals were systematically reviewed. Heterogeneity was assessed using the Cochrane Q statistic. RESULTS: Eighteen out of 432 available search output were eligible and included for this study. Of which 13 and 5 were WNV studies on humans and animals, respectively. Although 61.5% of the human studies had a low risk of bias, they all had high heterogeneity. The South West geopolitical zone of Nigeria had the highest pooled prevalence of anti-WNV immunoglobulin M (IgM; 7.8% in humans). The pooled seroprevalence of anti-WNV IgM and immunoglobulin G (IgG) was 7.1% (95% confidence interval [CI], 5.9 to 8.3) and 76.5% (95% CI, 74.0 to 78.8), respectively. The WNV RNA prevalence was 1.9% (95% CI, 1.4 to 2.9), while 14.3% (95% CI, 12.9 to 15.8) had WNV-neutralizing antibodies. In animals, the pooled seroprevalence of anti-WNV IgM and IgG was 90.3% (95% CI, 84.3 to 94.6) and 3.5% (95% CI, 1.9 to 5.8), respectively, while 20.0% (95% CI, 12.9 to 21.4) had WNV-neutralizing antibodies. Age (odds ratio [OR], 3.73; 95% CI, 1.87 to 7.45; p\textless0.001) and level of education (no formal education: OR, 4.31; 95% CI, 1.08 to 17.2; p\textless0.05; primary: OR, 7.29; 95% CI, 1.80 to 29.6; p\textless0.01) were significant risk factors for WNV IgM seropositivity in humans. CONCLUSIONS: The findings of this study highlight the endemicity of WNV in animals and humans in Nigeria and underscore the need for the One Health prevention and control approach.</p>
  

  <h2>Citation</h2>
  <p class="citation"><span id="abdullahi_distribution_2020">Abdullahi, I. N., Emeribe, A. U., Ghamba, P. E., Omosigho, P. O., Bello, Z. M., Oderinde, B. S., Fasogbon, S. A., Olayemi, L., Daneji, I. M., Musa, M. H., Nwofe, J. O., Onukegbe, N. B., Okume, C. C., Musa, S., Gwarzo, A. M., &amp; Ajagbe, O. O. R. (2020). Distribution pattern and prevalence of West Nile virus infection in Nigeria from 1950 to 2020: a systematic review. <i>Epidemiol Health</i>, <i>42</i>, e2020071. https://doi.org/10.4178/epih.e2020071 <b>Animals, Humans, Prevalence, One Health, Zoonosis, Nigeria, Nigeria/epidemiology, Pooled prevalence, West Nile Fever/*epidemiology/veterinary, West Nile virus</b></span> </p>


  <h2>Keywords</h2>
  <ul>
    
    
      <li>Animals</li>
    
      <li>Humans</li>
    
      <li>Prevalence</li>
    
      <li>One Health</li>
    
      <li>Zoonosis</li>
    
      <li>Nigeria</li>
    
      <li>Nigeria/epidemiology</li>
    
      <li>Pooled prevalence</li>
    
      <li>West Nile Fever/*epidemiology/veterinary</li>
    
      <li>West Nile virus</li>
    
  </ul>

</div>

  </div>

  <!-- FOOTER -->
  <div class="container">
    <div class="footer">


      <h3>VetSRev</h3>
      <p class="strap">Database of veterinary systematic reviews</p>

      <p>To cite this resource please use the following:</br>
      Veterinary Systematic Review database (2021) VetSRev database (Version 2.0). Available at: https://vetsrev.nottingham.ac.uk.</p>


      <p class="smallprint"><a href="/cookies.html">Cookies policy</a></p>

    </div>
  </div>

  <!-- Cookie-Alert -->
  <div class="alert alert-dark alert-dismissible cookiealert" role="alert">

    We'd like to set some analytics cookies to help us improve our website.

    <a href="/cookies/">Learn more.</a>
    <button type="button" class="btn btn-outline-secondary btn-sm declinecookies" data-dismiss="alert">Decline</button>
    <button type="button" class="btn btn-primary btn-sm acceptcookies">Accept</button>

    <button type="button" class="close" data-dismiss="alert" aria-label="Close">
      <span aria-hidden="true">&times;</span>
    </button>
  </div>


  <!-- jQuery first, then Popper.js, then Bootstrap JS -->
  <script src="/vendor/jquery-3.5.1.min.js"></script>
  <script src="/vendor/popper.min.js "></script>
  <script src="/vendor/bootstrap-4.3.1.min.js "></script>

  


  


  <!-- cookies and Google Analytics-->
  <script src="/assets/cookies.js "></script>

</body>
</html>
